Global Biologic Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Biologic Drugs Industry Forecast” looks at past sales and reviews total world Biologic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologic Drugs sales for 2023 through 2029. With Biologic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Biologic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biologic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Drugs.
The global Biologic Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biologic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biologic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biologic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biologic Drugs players cover Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Pfizer, Amgen, Sanofi, Novartis and Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Biologic Drugs market?
What factors are driving Biologic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biologic Drugs market opportunities vary by end market size?
How does Biologic Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Biologic Drugs Industry Forecast” looks at past sales and reviews total world Biologic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologic Drugs sales for 2023 through 2029. With Biologic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Biologic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biologic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Drugs.
The global Biologic Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Biologic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Biologic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Biologic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Biologic Drugs players cover Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Pfizer, Amgen, Sanofi, Novartis and Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Humira
- Remicade
- Rituxan
- Enbrel
- Lantus
- Avastin
- Herceptin
- Others
- Diabetes
- Inflammation
- Auto-Immune Diseases
- Blood Diseases
- Cardiovascular Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Merck & Co.
- Pfizer
- Amgen
- Sanofi
- Novartis
- Eli Lilly
- Amgen
What is the 10-year outlook for the global Biologic Drugs market?
What factors are driving Biologic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biologic Drugs market opportunities vary by end market size?
How does Biologic Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biologic Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biologic Drugs by Country/Region, 2018, 2022 & 2029
2.2 Biologic Drugs Segment by Type
2.2.1 Humira
2.2.2 Remicade
2.2.3 Rituxan
2.2.4 Enbrel
2.2.5 Lantus
2.2.6 Avastin
2.2.7 Herceptin
2.2.8 Others
2.3 Biologic Drugs Sales by Type
2.3.1 Global Biologic Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Biologic Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biologic Drugs Sale Price by Type (2018-2023)
2.4 Biologic Drugs Segment by Application
2.4.1 Diabetes
2.4.2 Inflammation
2.4.3 Auto-Immune Diseases
2.4.4 Blood Diseases
2.4.5 Cardiovascular Diseases
2.4.6 Others
2.5 Biologic Drugs Sales by Application
2.5.1 Global Biologic Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Biologic Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biologic Drugs Sale Price by Application (2018-2023)
3 GLOBAL BIOLOGIC DRUGS BY COMPANY
3.1 Global Biologic Drugs Breakdown Data by Company
3.1.1 Global Biologic Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Biologic Drugs Sales Market Share by Company (2018-2023)
3.2 Global Biologic Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Biologic Drugs Revenue by Company (2018-2023)
3.2.2 Global Biologic Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Biologic Drugs Sale Price by Company
3.4 Key Manufacturers Biologic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologic Drugs Product Location Distribution
3.4.2 Players Biologic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Biologic Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Biologic Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biologic Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biologic Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Biologic Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biologic Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biologic Drugs Sales Growth
4.4 APAC Biologic Drugs Sales Growth
4.5 Europe Biologic Drugs Sales Growth
4.6 Middle East & Africa Biologic Drugs Sales Growth
5 AMERICAS
5.1 Americas Biologic Drugs Sales by Country
5.1.1 Americas Biologic Drugs Sales by Country (2018-2023)
5.1.2 Americas Biologic Drugs Revenue by Country (2018-2023)
5.2 Americas Biologic Drugs Sales by Type
5.3 Americas Biologic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Drugs Sales by Region
6.1.1 APAC Biologic Drugs Sales by Region (2018-2023)
6.1.2 APAC Biologic Drugs Revenue by Region (2018-2023)
6.2 APAC Biologic Drugs Sales by Type
6.3 APAC Biologic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologic Drugs by Country
7.1.1 Europe Biologic Drugs Sales by Country (2018-2023)
7.1.2 Europe Biologic Drugs Revenue by Country (2018-2023)
7.2 Europe Biologic Drugs Sales by Type
7.3 Europe Biologic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Drugs by Country
8.1.1 Middle East & Africa Biologic Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biologic Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Biologic Drugs Sales by Type
8.3 Middle East & Africa Biologic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologic Drugs
10.3 Manufacturing Process Analysis of Biologic Drugs
10.4 Industry Chain Structure of Biologic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologic Drugs Distributors
11.3 Biologic Drugs Customer
12 WORLD FORECAST REVIEW FOR BIOLOGIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Biologic Drugs Market Size Forecast by Region
12.1.1 Global Biologic Drugs Forecast by Region (2024-2029)
12.1.2 Global Biologic Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biologic Drugs Forecast by Type
12.7 Global Biologic Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Biologic Drugs Product Portfolios and Specifications
13.1.3 Roche Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Biologic Drugs Product Portfolios and Specifications
13.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Biologic Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. Biologic Drugs Product Portfolios and Specifications
13.4.3 Merck & Co. Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Biologic Drugs Product Portfolios and Specifications
13.5.3 Pfizer Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Biologic Drugs Product Portfolios and Specifications
13.6.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Biologic Drugs Product Portfolios and Specifications
13.7.3 Sanofi Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Biologic Drugs Product Portfolios and Specifications
13.8.3 Novartis Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Biologic Drugs Product Portfolios and Specifications
13.9.3 Eli Lilly Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen Biologic Drugs Product Portfolios and Specifications
13.10.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Biologic Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Biologic Drugs by Country/Region, 2018, 2022 & 2029
2.2 Biologic Drugs Segment by Type
2.2.1 Humira
2.2.2 Remicade
2.2.3 Rituxan
2.2.4 Enbrel
2.2.5 Lantus
2.2.6 Avastin
2.2.7 Herceptin
2.2.8 Others
2.3 Biologic Drugs Sales by Type
2.3.1 Global Biologic Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Biologic Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Biologic Drugs Sale Price by Type (2018-2023)
2.4 Biologic Drugs Segment by Application
2.4.1 Diabetes
2.4.2 Inflammation
2.4.3 Auto-Immune Diseases
2.4.4 Blood Diseases
2.4.5 Cardiovascular Diseases
2.4.6 Others
2.5 Biologic Drugs Sales by Application
2.5.1 Global Biologic Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Biologic Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Biologic Drugs Sale Price by Application (2018-2023)
3 GLOBAL BIOLOGIC DRUGS BY COMPANY
3.1 Global Biologic Drugs Breakdown Data by Company
3.1.1 Global Biologic Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Biologic Drugs Sales Market Share by Company (2018-2023)
3.2 Global Biologic Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Biologic Drugs Revenue by Company (2018-2023)
3.2.2 Global Biologic Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Biologic Drugs Sale Price by Company
3.4 Key Manufacturers Biologic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologic Drugs Product Location Distribution
3.4.2 Players Biologic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BIOLOGIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Biologic Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Biologic Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Biologic Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Biologic Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Biologic Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Biologic Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Biologic Drugs Sales Growth
4.4 APAC Biologic Drugs Sales Growth
4.5 Europe Biologic Drugs Sales Growth
4.6 Middle East & Africa Biologic Drugs Sales Growth
5 AMERICAS
5.1 Americas Biologic Drugs Sales by Country
5.1.1 Americas Biologic Drugs Sales by Country (2018-2023)
5.1.2 Americas Biologic Drugs Revenue by Country (2018-2023)
5.2 Americas Biologic Drugs Sales by Type
5.3 Americas Biologic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Drugs Sales by Region
6.1.1 APAC Biologic Drugs Sales by Region (2018-2023)
6.1.2 APAC Biologic Drugs Revenue by Region (2018-2023)
6.2 APAC Biologic Drugs Sales by Type
6.3 APAC Biologic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biologic Drugs by Country
7.1.1 Europe Biologic Drugs Sales by Country (2018-2023)
7.1.2 Europe Biologic Drugs Revenue by Country (2018-2023)
7.2 Europe Biologic Drugs Sales by Type
7.3 Europe Biologic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Drugs by Country
8.1.1 Middle East & Africa Biologic Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Biologic Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Biologic Drugs Sales by Type
8.3 Middle East & Africa Biologic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biologic Drugs
10.3 Manufacturing Process Analysis of Biologic Drugs
10.4 Industry Chain Structure of Biologic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biologic Drugs Distributors
11.3 Biologic Drugs Customer
12 WORLD FORECAST REVIEW FOR BIOLOGIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Biologic Drugs Market Size Forecast by Region
12.1.1 Global Biologic Drugs Forecast by Region (2024-2029)
12.1.2 Global Biologic Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biologic Drugs Forecast by Type
12.7 Global Biologic Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Biologic Drugs Product Portfolios and Specifications
13.1.3 Roche Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Biologic Drugs Product Portfolios and Specifications
13.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Biologic Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. Biologic Drugs Product Portfolios and Specifications
13.4.3 Merck & Co. Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Biologic Drugs Product Portfolios and Specifications
13.5.3 Pfizer Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Amgen
13.6.1 Amgen Company Information
13.6.2 Amgen Biologic Drugs Product Portfolios and Specifications
13.6.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Amgen Main Business Overview
13.6.5 Amgen Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Biologic Drugs Product Portfolios and Specifications
13.7.3 Sanofi Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Biologic Drugs Product Portfolios and Specifications
13.8.3 Novartis Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 Eli Lilly
13.9.1 Eli Lilly Company Information
13.9.2 Eli Lilly Biologic Drugs Product Portfolios and Specifications
13.9.3 Eli Lilly Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Eli Lilly Main Business Overview
13.9.5 Eli Lilly Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen Biologic Drugs Product Portfolios and Specifications
13.10.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologic Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biologic Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Humira
Table 4. Major Players of Remicade
Table 5. Major Players of Rituxan
Table 6. Major Players of Enbrel
Table 7. Major Players of Lantus
Table 8. Major Players of Avastin
Table 9. Major Players of Herceptin
Table 10. Major Players of Others
Table 11. Global Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 12. Global Biologic Drugs Sales Market Share by Type (2018-2023)
Table 13. Global Biologic Drugs Revenue by Type (2018-2023) & ($ million)
Table 14. Global Biologic Drugs Revenue Market Share by Type (2018-2023)
Table 15. Global Biologic Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 16. Global Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 17. Global Biologic Drugs Sales Market Share by Application (2018-2023)
Table 18. Global Biologic Drugs Revenue by Application (2018-2023)
Table 19. Global Biologic Drugs Revenue Market Share by Application (2018-2023)
Table 20. Global Biologic Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 21. Global Biologic Drugs Sales by Company (2018-2023) & (K Units)
Table 22. Global Biologic Drugs Sales Market Share by Company (2018-2023)
Table 23. Global Biologic Drugs Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Biologic Drugs Revenue Market Share by Company (2018-2023)
Table 25. Global Biologic Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 26. Key Manufacturers Biologic Drugs Producing Area Distribution and Sales Area
Table 27. Players Biologic Drugs Products Offered
Table 28. Biologic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Biologic Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 32. Global Biologic Drugs Sales Market Share Geographic Region (2018-2023)
Table 33. Global Biologic Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Biologic Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Biologic Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 36. Global Biologic Drugs Sales Market Share by Country/Region (2018-2023)
Table 37. Global Biologic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Biologic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Biologic Drugs Sales by Country (2018-2023) & (K Units)
Table 40. Americas Biologic Drugs Sales Market Share by Country (2018-2023)
Table 41. Americas Biologic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Biologic Drugs Revenue Market Share by Country (2018-2023)
Table 43. Americas Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 44. Americas Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 45. APAC Biologic Drugs Sales by Region (2018-2023) & (K Units)
Table 46. APAC Biologic Drugs Sales Market Share by Region (2018-2023)
Table 47. APAC Biologic Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Biologic Drugs Revenue Market Share by Region (2018-2023)
Table 49. APAC Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 50. APAC Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Europe Biologic Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Europe Biologic Drugs Sales Market Share by Country (2018-2023)
Table 53. Europe Biologic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Biologic Drugs Revenue Market Share by Country (2018-2023)
Table 55. Europe Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Europe Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Middle East & Africa Biologic Drugs Sales by Country (2018-2023) & (K Units)
Table 58. Middle East & Africa Biologic Drugs Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Biologic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Biologic Drugs Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 62. Middle East & Africa Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 63. Key Market Drivers & Growth Opportunities of Biologic Drugs
Table 64. Key Market Challenges & Risks of Biologic Drugs
Table 65. Key Industry Trends of Biologic Drugs
Table 66. Biologic Drugs Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Biologic Drugs Distributors List
Table 69. Biologic Drugs Customer List
Table 70. Global Biologic Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. Global Biologic Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Biologic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Americas Biologic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Biologic Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 75. APAC Biologic Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Biologic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Europe Biologic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Biologic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 79. Middle East & Africa Biologic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Biologic Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 81. Global Biologic Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Biologic Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 83. Global Biologic Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Roche Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Biologic Drugs Product Portfolios and Specifications
Table 86. Roche Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. Abbott Laboratories Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Abbott Laboratories Biologic Drugs Product Portfolios and Specifications
Table 91. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Abbott Laboratories Main Business
Table 93. Abbott Laboratories Latest Developments
Table 94. Johnson & Johnson Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Johnson & Johnson Biologic Drugs Product Portfolios and Specifications
Table 96. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Johnson & Johnson Main Business
Table 98. Johnson & Johnson Latest Developments
Table 99. Merck & Co. Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck & Co. Biologic Drugs Product Portfolios and Specifications
Table 101. Merck & Co. Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Merck & Co. Main Business
Table 103. Merck & Co. Latest Developments
Table 104. Pfizer Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Biologic Drugs Product Portfolios and Specifications
Table 106. Pfizer Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Amgen Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Amgen Biologic Drugs Product Portfolios and Specifications
Table 111. Amgen Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Amgen Main Business
Table 113. Amgen Latest Developments
Table 114. Sanofi Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanofi Biologic Drugs Product Portfolios and Specifications
Table 116. Sanofi Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Sanofi Main Business
Table 118. Sanofi Latest Developments
Table 119. Novartis Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Biologic Drugs Product Portfolios and Specifications
Table 121. Novartis Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. Eli Lilly Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Eli Lilly Biologic Drugs Product Portfolios and Specifications
Table 126. Eli Lilly Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Eli Lilly Main Business
Table 128. Eli Lilly Latest Developments
Table 129. Amgen Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Amgen Biologic Drugs Product Portfolios and Specifications
Table 131. Amgen Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Amgen Main Business
Table 133. Amgen Latest Developments
Table 1. Biologic Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Biologic Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Humira
Table 4. Major Players of Remicade
Table 5. Major Players of Rituxan
Table 6. Major Players of Enbrel
Table 7. Major Players of Lantus
Table 8. Major Players of Avastin
Table 9. Major Players of Herceptin
Table 10. Major Players of Others
Table 11. Global Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 12. Global Biologic Drugs Sales Market Share by Type (2018-2023)
Table 13. Global Biologic Drugs Revenue by Type (2018-2023) & ($ million)
Table 14. Global Biologic Drugs Revenue Market Share by Type (2018-2023)
Table 15. Global Biologic Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 16. Global Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 17. Global Biologic Drugs Sales Market Share by Application (2018-2023)
Table 18. Global Biologic Drugs Revenue by Application (2018-2023)
Table 19. Global Biologic Drugs Revenue Market Share by Application (2018-2023)
Table 20. Global Biologic Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 21. Global Biologic Drugs Sales by Company (2018-2023) & (K Units)
Table 22. Global Biologic Drugs Sales Market Share by Company (2018-2023)
Table 23. Global Biologic Drugs Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Biologic Drugs Revenue Market Share by Company (2018-2023)
Table 25. Global Biologic Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 26. Key Manufacturers Biologic Drugs Producing Area Distribution and Sales Area
Table 27. Players Biologic Drugs Products Offered
Table 28. Biologic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Biologic Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 32. Global Biologic Drugs Sales Market Share Geographic Region (2018-2023)
Table 33. Global Biologic Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Biologic Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Biologic Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 36. Global Biologic Drugs Sales Market Share by Country/Region (2018-2023)
Table 37. Global Biologic Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Biologic Drugs Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Biologic Drugs Sales by Country (2018-2023) & (K Units)
Table 40. Americas Biologic Drugs Sales Market Share by Country (2018-2023)
Table 41. Americas Biologic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Biologic Drugs Revenue Market Share by Country (2018-2023)
Table 43. Americas Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 44. Americas Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 45. APAC Biologic Drugs Sales by Region (2018-2023) & (K Units)
Table 46. APAC Biologic Drugs Sales Market Share by Region (2018-2023)
Table 47. APAC Biologic Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Biologic Drugs Revenue Market Share by Region (2018-2023)
Table 49. APAC Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 50. APAC Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Europe Biologic Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Europe Biologic Drugs Sales Market Share by Country (2018-2023)
Table 53. Europe Biologic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Biologic Drugs Revenue Market Share by Country (2018-2023)
Table 55. Europe Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Europe Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Middle East & Africa Biologic Drugs Sales by Country (2018-2023) & (K Units)
Table 58. Middle East & Africa Biologic Drugs Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Biologic Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Biologic Drugs Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Biologic Drugs Sales by Type (2018-2023) & (K Units)
Table 62. Middle East & Africa Biologic Drugs Sales by Application (2018-2023) & (K Units)
Table 63. Key Market Drivers & Growth Opportunities of Biologic Drugs
Table 64. Key Market Challenges & Risks of Biologic Drugs
Table 65. Key Industry Trends of Biologic Drugs
Table 66. Biologic Drugs Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Biologic Drugs Distributors List
Table 69. Biologic Drugs Customer List
Table 70. Global Biologic Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. Global Biologic Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Biologic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Americas Biologic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Biologic Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 75. APAC Biologic Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Biologic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Europe Biologic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Biologic Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 79. Middle East & Africa Biologic Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Biologic Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 81. Global Biologic Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Biologic Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 83. Global Biologic Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Roche Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche Biologic Drugs Product Portfolios and Specifications
Table 86. Roche Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. Abbott Laboratories Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Abbott Laboratories Biologic Drugs Product Portfolios and Specifications
Table 91. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Abbott Laboratories Main Business
Table 93. Abbott Laboratories Latest Developments
Table 94. Johnson & Johnson Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Johnson & Johnson Biologic Drugs Product Portfolios and Specifications
Table 96. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Johnson & Johnson Main Business
Table 98. Johnson & Johnson Latest Developments
Table 99. Merck & Co. Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck & Co. Biologic Drugs Product Portfolios and Specifications
Table 101. Merck & Co. Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Merck & Co. Main Business
Table 103. Merck & Co. Latest Developments
Table 104. Pfizer Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Biologic Drugs Product Portfolios and Specifications
Table 106. Pfizer Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Amgen Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Amgen Biologic Drugs Product Portfolios and Specifications
Table 111. Amgen Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Amgen Main Business
Table 113. Amgen Latest Developments
Table 114. Sanofi Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanofi Biologic Drugs Product Portfolios and Specifications
Table 116. Sanofi Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Sanofi Main Business
Table 118. Sanofi Latest Developments
Table 119. Novartis Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Biologic Drugs Product Portfolios and Specifications
Table 121. Novartis Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. Eli Lilly Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Eli Lilly Biologic Drugs Product Portfolios and Specifications
Table 126. Eli Lilly Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Eli Lilly Main Business
Table 128. Eli Lilly Latest Developments
Table 129. Amgen Basic Information, Biologic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Amgen Biologic Drugs Product Portfolios and Specifications
Table 131. Amgen Biologic Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Amgen Main Business
Table 133. Amgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biologic Drugs
Figure 2. Biologic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologic Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Biologic Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biologic Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Humira
Figure 10. Product Picture of Remicade
Figure 11. Product Picture of Rituxan
Figure 12. Product Picture of Enbrel
Figure 13. Product Picture of Lantus
Figure 14. Product Picture of Avastin
Figure 15. Product Picture of Herceptin
Figure 16. Product Picture of Others
Figure 17. Global Biologic Drugs Sales Market Share by Type in 2022
Figure 18. Global Biologic Drugs Revenue Market Share by Type (2018-2023)
Figure 19. Biologic Drugs Consumed in Diabetes
Figure 20. Global Biologic Drugs Market: Diabetes (2018-2023) & (K Units)
Figure 21. Biologic Drugs Consumed in Inflammation
Figure 22. Global Biologic Drugs Market: Inflammation (2018-2023) & (K Units)
Figure 23. Biologic Drugs Consumed in Auto-Immune Diseases
Figure 24. Global Biologic Drugs Market: Auto-Immune Diseases (2018-2023) & (K Units)
Figure 25. Biologic Drugs Consumed in Blood Diseases
Figure 26. Global Biologic Drugs Market: Blood Diseases (2018-2023) & (K Units)
Figure 27. Biologic Drugs Consumed in Cardiovascular Diseases
Figure 28. Global Biologic Drugs Market: Cardiovascular Diseases (2018-2023) & (K Units)
Figure 29. Biologic Drugs Consumed in Others
Figure 30. Global Biologic Drugs Market: Others (2018-2023) & (K Units)
Figure 31. Global Biologic Drugs Sales Market Share by Application (2022)
Figure 32. Global Biologic Drugs Revenue Market Share by Application in 2022
Figure 33. Biologic Drugs Sales Market by Company in 2022 (K Units)
Figure 34. Global Biologic Drugs Sales Market Share by Company in 2022
Figure 35. Biologic Drugs Revenue Market by Company in 2022 ($ Million)
Figure 36. Global Biologic Drugs Revenue Market Share by Company in 2022
Figure 37. Global Biologic Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 38. Global Biologic Drugs Revenue Market Share by Geographic Region in 2022
Figure 39. Americas Biologic Drugs Sales 2018-2023 (K Units)
Figure 40. Americas Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 41. APAC Biologic Drugs Sales 2018-2023 (K Units)
Figure 42. APAC Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Europe Biologic Drugs Sales 2018-2023 (K Units)
Figure 44. Europe Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Biologic Drugs Sales 2018-2023 (K Units)
Figure 46. Middle East & Africa Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 47. Americas Biologic Drugs Sales Market Share by Country in 2022
Figure 48. Americas Biologic Drugs Revenue Market Share by Country in 2022
Figure 49. Americas Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 50. Americas Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 51. United States Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Canada Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Mexico Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Brazil Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. APAC Biologic Drugs Sales Market Share by Region in 2022
Figure 56. APAC Biologic Drugs Revenue Market Share by Regions in 2022
Figure 57. APAC Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 58. APAC Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 59. China Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Japan Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. South Korea Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Southeast Asia Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. India Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Australia Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. China Taiwan Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Europe Biologic Drugs Sales Market Share by Country in 2022
Figure 67. Europe Biologic Drugs Revenue Market Share by Country in 2022
Figure 68. Europe Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 69. Europe Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 70. Germany Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. France Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. UK Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Italy Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Russia Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Middle East & Africa Biologic Drugs Sales Market Share by Country in 2022
Figure 76. Middle East & Africa Biologic Drugs Revenue Market Share by Country in 2022
Figure 77. Middle East & Africa Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 78. Middle East & Africa Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 79. Egypt Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. South Africa Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 81. Israel Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 82. Turkey Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 83. GCC Country Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 84. Manufacturing Cost Structure Analysis of Biologic Drugs in 2022
Figure 85. Manufacturing Process Analysis of Biologic Drugs
Figure 86. Industry Chain Structure of Biologic Drugs
Figure 87. Channels of Distribution
Figure 88. Global Biologic Drugs Sales Market Forecast by Region (2024-2029)
Figure 89. Global Biologic Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 90. Global Biologic Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 91. Global Biologic Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 92. Global Biologic Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 93. Global Biologic Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Biologic Drugs
Figure 2. Biologic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologic Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Biologic Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Biologic Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Humira
Figure 10. Product Picture of Remicade
Figure 11. Product Picture of Rituxan
Figure 12. Product Picture of Enbrel
Figure 13. Product Picture of Lantus
Figure 14. Product Picture of Avastin
Figure 15. Product Picture of Herceptin
Figure 16. Product Picture of Others
Figure 17. Global Biologic Drugs Sales Market Share by Type in 2022
Figure 18. Global Biologic Drugs Revenue Market Share by Type (2018-2023)
Figure 19. Biologic Drugs Consumed in Diabetes
Figure 20. Global Biologic Drugs Market: Diabetes (2018-2023) & (K Units)
Figure 21. Biologic Drugs Consumed in Inflammation
Figure 22. Global Biologic Drugs Market: Inflammation (2018-2023) & (K Units)
Figure 23. Biologic Drugs Consumed in Auto-Immune Diseases
Figure 24. Global Biologic Drugs Market: Auto-Immune Diseases (2018-2023) & (K Units)
Figure 25. Biologic Drugs Consumed in Blood Diseases
Figure 26. Global Biologic Drugs Market: Blood Diseases (2018-2023) & (K Units)
Figure 27. Biologic Drugs Consumed in Cardiovascular Diseases
Figure 28. Global Biologic Drugs Market: Cardiovascular Diseases (2018-2023) & (K Units)
Figure 29. Biologic Drugs Consumed in Others
Figure 30. Global Biologic Drugs Market: Others (2018-2023) & (K Units)
Figure 31. Global Biologic Drugs Sales Market Share by Application (2022)
Figure 32. Global Biologic Drugs Revenue Market Share by Application in 2022
Figure 33. Biologic Drugs Sales Market by Company in 2022 (K Units)
Figure 34. Global Biologic Drugs Sales Market Share by Company in 2022
Figure 35. Biologic Drugs Revenue Market by Company in 2022 ($ Million)
Figure 36. Global Biologic Drugs Revenue Market Share by Company in 2022
Figure 37. Global Biologic Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 38. Global Biologic Drugs Revenue Market Share by Geographic Region in 2022
Figure 39. Americas Biologic Drugs Sales 2018-2023 (K Units)
Figure 40. Americas Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 41. APAC Biologic Drugs Sales 2018-2023 (K Units)
Figure 42. APAC Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 43. Europe Biologic Drugs Sales 2018-2023 (K Units)
Figure 44. Europe Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Biologic Drugs Sales 2018-2023 (K Units)
Figure 46. Middle East & Africa Biologic Drugs Revenue 2018-2023 ($ Millions)
Figure 47. Americas Biologic Drugs Sales Market Share by Country in 2022
Figure 48. Americas Biologic Drugs Revenue Market Share by Country in 2022
Figure 49. Americas Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 50. Americas Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 51. United States Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Canada Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. Mexico Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Brazil Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. APAC Biologic Drugs Sales Market Share by Region in 2022
Figure 56. APAC Biologic Drugs Revenue Market Share by Regions in 2022
Figure 57. APAC Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 58. APAC Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 59. China Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Japan Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. South Korea Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Southeast Asia Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. India Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. Australia Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. China Taiwan Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Europe Biologic Drugs Sales Market Share by Country in 2022
Figure 67. Europe Biologic Drugs Revenue Market Share by Country in 2022
Figure 68. Europe Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 69. Europe Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 70. Germany Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. France Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. UK Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Italy Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Russia Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Middle East & Africa Biologic Drugs Sales Market Share by Country in 2022
Figure 76. Middle East & Africa Biologic Drugs Revenue Market Share by Country in 2022
Figure 77. Middle East & Africa Biologic Drugs Sales Market Share by Type (2018-2023)
Figure 78. Middle East & Africa Biologic Drugs Sales Market Share by Application (2018-2023)
Figure 79. Egypt Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 80. South Africa Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 81. Israel Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 82. Turkey Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 83. GCC Country Biologic Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 84. Manufacturing Cost Structure Analysis of Biologic Drugs in 2022
Figure 85. Manufacturing Process Analysis of Biologic Drugs
Figure 86. Industry Chain Structure of Biologic Drugs
Figure 87. Channels of Distribution
Figure 88. Global Biologic Drugs Sales Market Forecast by Region (2024-2029)
Figure 89. Global Biologic Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 90. Global Biologic Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 91. Global Biologic Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 92. Global Biologic Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 93. Global Biologic Drugs Revenue Market Share Forecast by Application (2024-2029)
